126 related articles for article (PubMed ID: 9767634)
1. Structure-based design of beta-lactamase inhibitors. 2. Synthesis and evaluation of bridged sulfactams and oxamazins.
Hubschwerlen C; Angehrn P; Gubernator K; Page MG; Specklin JL
J Med Chem; 1998 Oct; 41(21):3972-5. PubMed ID: 9767634
[TBL] [Abstract][Full Text] [Related]
2. Structure-based design of beta-lactamase inhibitors. 1. Synthesis and evaluation of bridged monobactams.
Heinze-Krauss I; Angehrn P; Charnas RL; Gubernator K; Gutknecht EM; Hubschwerlen C; Kania M; Oefner C; Page MG; Sogabe S; Specklin JL; Winkler F
J Med Chem; 1998 Oct; 41(21):3961-71. PubMed ID: 9767633
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and evaluation of 2 beta-alkenyl penam sulfone acids as inhibitors of beta-lactamases.
Richter HG; Angehrn P; Hubschwerlen C; Kania M; Page MG; Specklin JL; Winkler FK
J Med Chem; 1996 Sep; 39(19):3712-22. PubMed ID: 8809160
[TBL] [Abstract][Full Text] [Related]
4. Spirocyclopropyl beta-lactams as mechanism-based inhibitors of serine beta-lactamases. Synthesis by rhodium-catalyzed cyclopropanation of 6-diazopenicillanate sulfone.
Sandanayaka VP; Prashad AS; Yang Y; Williamson RT; Lin YI; Mansour TS
J Med Chem; 2003 Jun; 46(13):2569-71. PubMed ID: 12801220
[TBL] [Abstract][Full Text] [Related]
5. Structure-based enhancement of boronic acid-based inhibitors of AmpC beta-lactamase.
Weston GS; Blázquez J; Baquero F; Shoichet BK
J Med Chem; 1998 Nov; 41(23):4577-86. PubMed ID: 9804697
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationship of 6-methylidene penems bearing tricyclic heterocycles as broad-spectrum beta-lactamase inhibitors: crystallographic structures show unexpected binding of 1,4-thiazepine intermediates.
Venkatesan AM; Gu Y; Dos Santos O; Abe T; Agarwal A; Yang Y; Petersen PJ; Weiss WJ; Mansour TS; Nukaga M; Hujer AM; Bonomo RA; Knox JR
J Med Chem; 2004 Dec; 47(26):6556-68. PubMed ID: 15588091
[TBL] [Abstract][Full Text] [Related]
7. Inhibitors of metallo-beta-lactamase generated from beta-lactam antibiotics.
Badarau A; Llinás A; Laws AP; Damblon C; Page MI
Biochemistry; 2005 Jun; 44(24):8578-89. PubMed ID: 15952764
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of penam sulfones as inhibitors of beta-lactamases.
Phillips OA; Reddy AV; Setti EL; Spevak P; Czajkowski DP; Atwal H; Salama S; Micetich RG; Maiti SN
Bioorg Med Chem; 2005 Apr; 13(8):2847-58. PubMed ID: 15781395
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antimicrobial evaluation of 2 beta-chloromethyl-6 beta-carbamoylmethyl-penam-1,1-dioxide-3-carboxylic acid.
Gaviraghi G; Perboni A; Tamburini B; Xerri L; Salvatori A; Spadoni G; Tarzia G
Farmaco; 1996 Jul; 51(7):535-8. PubMed ID: 8765676
[TBL] [Abstract][Full Text] [Related]
10. Pharmacodynamic study of beta-lactams alone and in combination with beta-lactamase inhibitors against Pseudomonas aeruginosa possessing an inducible beta-lactamase.
Li C; Nicolau DP; Lister PD; Quintiliani R; Nightingale CH
J Antimicrob Chemother; 2004 Feb; 53(2):297-304. PubMed ID: 14729755
[TBL] [Abstract][Full Text] [Related]
11. Aza-boronic acids as non-beta-lactam inhibitors of AmpC-beta-lactamase.
Buzzoni V; Blazquez J; Ferrari S; Calò S; Venturelli A; Costi MP
Bioorg Med Chem Lett; 2004 Aug; 14(15):3979-83. PubMed ID: 15225711
[TBL] [Abstract][Full Text] [Related]
12. Assays for beta-lactamase activity and inhibition.
Viswanatha T; Marrone L; Goodfellow V; Dmitrienko GI
Methods Mol Med; 2008; 142():239-60. PubMed ID: 18437319
[TBL] [Abstract][Full Text] [Related]
13. Semisynthetic beta-lactam antibiotics. 6. 1 Sulfocephalosporins and their antipseudomonal activities.
Nomura H; Fugono T; Hitaka T; Minami I; Azuma T; Morimoto S; Masuda T
J Med Chem; 1974 Dec; 17(12):1312-5. PubMed ID: 4214929
[No Abstract] [Full Text] [Related]
14. Nanomolar inhibitors of AmpC beta-lactamase.
Morandi F; Caselli E; Morandi S; Focia PJ; Blázquez J; Shoichet BK; Prati F
J Am Chem Soc; 2003 Jan; 125(3):685-95. PubMed ID: 12526668
[TBL] [Abstract][Full Text] [Related]
15. In vitro efficacy of ceftriaxone/sulbactam against Escherichia coli isolates producing CTX-M-15 extended-spectrum beta-lactamase.
Shahid M; Singhai M; Malik A; Shukla I; Khan HM; Shujatullah F; Tahira F
J Antimicrob Chemother; 2007 Jul; 60(1):187-8. PubMed ID: 17491002
[No Abstract] [Full Text] [Related]
16. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
Susić E
Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687
[TBL] [Abstract][Full Text] [Related]
17. Exploring the effectiveness of tazobactam against ceftazidime resistant Escherichia coli: insights from the comparison between susceptibility testing and beta-lactamase inhibition.
Bethel CR; Hujer AM; Helfand MS; Bonomo RA
FEMS Microbiol Lett; 2004 May; 234(1):99-103. PubMed ID: 15109726
[TBL] [Abstract][Full Text] [Related]
18. A kinetic study on the interaction between tazobactam (a penicillanic acid sulphone derivative) and active-site serine beta-lactamases.
Perilli M; Franceschini N; Bonfiglio G; Segatore B; Stefani S; Nicoletti G; Perez MM; Bianchi C; Zollo A; Amicosante G
J Enzyme Inhib; 2000; 15(1):1-10. PubMed ID: 10850951
[TBL] [Abstract][Full Text] [Related]
19. Selective trihydroxyazepane NagZ inhibitors increase sensitivity of Pseudomonas aeruginosa to β-lactams.
Mondon M; Hur S; Vadlamani G; Rodrigues P; Tsybina P; Oliver A; Mark BL; Vocadlo DJ; Blériot Y
Chem Commun (Camb); 2013 Dec; 49(93):10983-5. PubMed ID: 24136176
[TBL] [Abstract][Full Text] [Related]
20. Comparative activity of beta-lactamase inhibitors combined with beta-lactams against antibiotic-resistant enterobacter.
Tejedor-Junco MT; Gonzalez-Martin M; Lupiola PA; Santana OE; Lopez-Orge RH; Gonzalez-Lama Z
J Chemother; 1989 Jul; 1(4 Suppl):346-8. PubMed ID: 16312432
[No Abstract] [Full Text] [Related]
[Next] [New Search]
